Mettler-Toledo International Inc. — FY 2014 Form 10-K
Period: Fiscal year ended December 31, 2014. The filing reports full-year results and unaudited quarterly data, including fourth-quarter 2014. Amounts below are in U.S. dollars; financial statement figures are in millions unless stated otherwise.
Business context and reporting period
Mettler-Toledo is a global supplier of precision instruments and related services, including laboratory and industrial weighing, analytical instruments, process analytics, product inspection, and food-retail solutions. It reports five operating segments: U.S., Swiss, Western European, Chinese, and Other operations. No customer represented more than 1% of 2014 sales.
Financial results and liquidity
| Metric | FY 2014 | FY 2013 | Change |
|---|---|---|---|
| Net sales | $2,486.0 | $2,379.0 | +4% reported; +5% local currency |
| Gross profit / gross margin | $1,358.8 / 54.7% | $1,281.9 / 53.9% | Margin +0.8 percentage points |
| Earnings before taxes | $445.0 | $402.7 | +10% |
| Net earnings | $338.2 | $306.1 | +11% |
| Diluted EPS | $11.44 | $9.96 | +15% |
| Cash from operating activities | $418.9 | $345.9 | +$73.0 |
| Capital expenditures | $89.4 | $82.3 | +$7.0 |
| Cash and equivalents, year-end | $85.3 | $111.9 | -$26.6 |
| Total debt, year-end | $452.0 | $413.0 | +$38.9 |
Net debt was approximately $366.7 million. The company had $684.8 million available under its $800 million revolving credit facility. Standard current assets less current liabilities were $170.5 million; the filing’s adjusted working-capital measure was $201.4 million. Interest expense was $24.5 million, and the effective tax rate was 24%.
Fourth-quarter 2014 sales were $697.4 million versus $684.3 million a year earlier (about +2%); net earnings were $121.2 million versus $110.2 million (about +10%). Diluted EPS was $4.17 versus $3.63.
Material changes versus prior comparable periods
- Annual sales growth accelerated from 2% reported in 2013 to 4% in 2014; local-currency growth rose from 1% to 5%.
- Gross margin improved, principally from favorable pricing and lower material costs. Product gross margin rose to 58.1% from 57.3%; service margin rose to 42.8% from 41.7%.
- Service revenue grew 7% in U.S. dollars and 8% in local currencies. Laboratory-related sales increased 6%; industrial-related sales increased 4%; retail sales increased 2%.
- Segment profit rose to $506.9 million from $472.9 million. Swiss, Western European, Chinese, and Other segment profits increased; U.S. segment profit declined 3% to $134.0 million.
- Chinese external-customer sales grew 2% in U.S. dollars, but local industrial market conditions remained weak. Exiting certain Chinese industrial businesses reduced local-currency external sales by about 2%.
- Restructuring charges fell to $5.9 million from $19.8 million. Share repurchases increased to $414.0 million from $295.0 million, reducing year-end outstanding shares.
- Despite higher earnings, comprehensive income fell to $160.3 million from $368.5 million, mainly reflecting $177.9 million of other comprehensive loss, including currency translation and pension-related items. Shareholders’ equity declined to $719.6 million from $935.1 million.
Outlook, commentary, risks, and unusual items
- Management described 2015 growth strategies including market-share initiatives, adding about 200 field sales and service resources, expansion in emerging markets, continued R&D investment, cost optimization, and selective acquisitions. It was cautious on sales growth because global conditions remained uncertain; no specific 2015 revenue or EPS guidance is stated in the provided filing text.
- Management cited stronger 2014 demand in laboratory markets and product inspection, while Chinese industrial demand was weak amid overcapacity and restricted customer credit. Emerging-market sales increased 3% in local currency.
- Foreign-exchange exposure is material, especially to the Swiss franc, euro, and U.S. dollar. In January 2015, after the Swiss National Bank abandoned its euro exchange-rate floor, the company entered forward contracts covering euro exposures through 2016. Management estimated that, absent those hedges, a 1% Swiss-franc strengthening against the euro could reduce annual pretax earnings by $1.1–$1.3 million.
- Debt included $100 million of 6.30% senior notes due June 2015; the company also planned to issue another $125 million of ten-year notes in June 2015. It reported compliance with debt covenants at year-end. Contractual obligations totaled $921.6 million, including debt, interest, leases, pension funding, and purchase obligations.
- Defined-benefit plans had a combined underfunded status of $148.5 million at year-end, compared with $53.2 million in 2013; pension assumptions and market movements affect reported obligations and future expense. The company made $18.0 million of voluntary incremental pension contributions in 2014.
- Environmental matters include ongoing monitoring and remediation at a New Jersey groundwater site, with estimated compliance costs of about $0.4 million over the next several years. Management did not expect current legal proceedings to materially affect results or financial condition, but noted possible future environmental liabilities.
- Other disclosed risks include economic and capital-spending weakness, China concentration, currency movements, competition and margin pressure, cybersecurity and ERP implementation disruption, supply and manufacturing interruptions, tax exposures, and potential goodwill or intangible-asset impairment. No goodwill impairment was recorded in 2014.
Important facts for investors to verify
- Whether 2015 demand, pricing, and margin performance support management’s cautious growth outlook, particularly in China and Europe.
- The impact of the Swiss-franc move and subsequent hedges on earnings, cash flows, and debt translation.
- How the June 2015 note issuance and the $100 million note maturity affect borrowing needs, interest costs, and liquidity.
- Whether operating cash generation can sustain substantial repurchases: $414.0 million in 2014, with $478.4 million remaining under the authorization at year-end.
- Whether pension funding needs, actuarial assumptions, and environmental or tax exposures change materially after year-end.
- Performance and cost progression of the Blue Ocean ERP rollout, restructuring efforts, and planned sales/service investments.